Who's Attending:
De-Silo End-to-End Process Development to Identify Inefficiencies, Deploy Disruptive Technologies & Ensure Consistently High-Quality Cell Therapy Products
_______________________________________________________
June 20-22, 2023 | Boston, MA
Welcome to the 2nd Process Development for Cell Therapies Summit: Driving Process Automation, Affordability & Scalability for Global Cell Therapies
As cell therapy success increasingly depends on commercial viability, scalability, and patient access, process development experts are crucial in driving efficiencies from early to late-stage development.
With the industry pipeline consolidating, it is more important than ever to employ quality by design and optimize processes for highly efficacious products that can easily transition from clinical trials to the market, securing competitive commercial viability.
Participate in the 2nd Process Development for Cell Therapies Summit alongside industry leaders to learn how to successfully deploy and commercialize novel and established cell therapy products in immunology and beyond. Gain valuable pre-competitive insights from fellow experts and peers on deploying platforms for automation, global scale-out, expedited phase development, and increased affordability.
Expert Speakers Include:
Join 80+ experts from the likes of BMS, Janssen, ArsenalBio, Bluebird Bio, Notch Therapeutics, Bayer, and more, looking to streamline cell therapy process development through sharing best practices and pre-competitive learnings to supercharge your pipeline development.
This is your opportunity to engage with the process development for the cell therapy industry, gain insights into best practices, and progress in a pre-competitive space.
For more details about the program, speaker faculty or pricing and discounts, download the brochure.
Join Industry Leaders to:

GAIN unrivaled access to a melting pot of industry experience to inform your development

DE-SILO process development to establish industry consensus and bring more therapies to patients faster

UNCOVER regulatory frameworks and novel technologies to develop global, data-driven processes